Investors / filer profile

Baskett Forest

active in 2 companies · 0 of 1 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 23
Filings: 2
Companies: 2026-02-09
Last filed

EDGAR · CIK 0001277631 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-13.4%

median move per position

+9.2%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$15.00M bought · −$5.7K sold

All filings on record

Every Form 4 transaction we track for this filer


SGPSpyGlass Pharma, Inc.	Convert — · 402,273 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 954,990 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Buy $15.00M · 937,500 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 737,962 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 1,370,168 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 1,370,168 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 1,619,240 sh	2026-02-09	—
NEUENeueHealth, Inc.	Return — · 674,554 sh	2025-10-02	—
NEUENeueHealth, Inc.	Tax $1.9K · 276 sh	2025-10-02	—
NEUENeueHealth, Inc.	Exercise $1.9K · 186,128 sh	2025-10-02	—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

402,273

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

954,990

—

SGPBuy

2026-02-09 · SpyGlass Pharma, Inc.

$15.00M

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

737,962

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

1,370,168

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

1,370,168

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

1,619,240

—

NEUEReturn

2025-10-02 · NeueHealth, Inc.

674,554

—

2025-10-02 · NeueHealth, Inc.

$1.9K

—

NEUEExercise

2025-10-02 · NeueHealth, Inc.

$1.9K

—

Newest 10 of 23 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.